November 4, 2026Stocks·Neutral·earnings
PMV Pharmaceuticals reports updated results from pivotal Phase 2 Rezatapopt PYNNACLE trial
PMV Pharmaceuticals reported updated results from its pivotal Phase 2 Rezatapopt PYNNACLE trial.
Detected & updated continuously · Source: Nebula
Story subjects